MicroRNA-335 inhibits invasion and metastasis of colorectal cancer by targeting ZEB2

MicroRNAs have been suggested to play a vital role in regulate tumor progression and invasion. However, the expression of miR-335 in colorectal cancer (CRC) and its clinical significance are not known. Here, we report that miR-335 is a tumor suppressor by regulating expression of ZEB2. In this study, we showed that downregulated miR-335 levels in highly invasive CRC cell lines and tissues. Kaplan–Meier survival analysis indicated that patients with reduced miR-335 had a poor overall survival. Furthermore, enhancing the expression of miR-335 inhibited CRC cell migration and invasion in vitro and lung and liver metastasis in vivo, while silencing its expression resulted in increased migration and invasion. Additionally, we identified a novel miR-335 target, ZEB2, and the direct interaction between them was verified by 3′-untranslated region dual-luciferase reporter assay. In conclusion, our results demonstrate that miR-335 functions as a tumor suppressor and play a role in inhibiting metastasis of CRC cells through targeting ZEB2. These findings suggest that miR-335 may be useful as a new potential therapeutic target for CRC.

[1]  Xijie Yu,et al.  MiR-335 Inhibits Small Cell Lung Cancer Bone Metastases via IGF-IR and RANKL Pathways , 2013, Molecular Cancer Research.

[2]  Yifeng Wang,et al.  MicroRNA-200a inhibits CD133/1+ ovarian cancer stem cells migration and invasion by targeting E-cadherin repressor ZEB2. , 2011, Gynecologic oncology.

[3]  Jin Cao,et al.  miR-335 represents an invasion suppressor gene in ovarian cancer by targeting Bcl-w. , 2013, Oncology reports.

[4]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[5]  Tianxin Lin,et al.  MicroRNA-335 Acts as a Candidate Tumor Suppressor in Prostate Cancer , 2013, Pathology & Oncology Research.

[6]  C. Croce,et al.  Targeting microRNAs in cancer: rationale, strategies and challenges , 2010, Nature Reviews Drug Discovery.

[7]  C. Croce,et al.  MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.

[8]  Elizabeth Garrett-Mayer,et al.  ZEB1-responsive genes in non-small cell lung cancer. , 2011, Cancer letters.

[9]  Andreas Rimner,et al.  MicroRNA-335 inhibits tumor reinitiation and is silenced through genetic and epigenetic mechanisms in human breast cancer. , 2011, Genes & development.

[10]  Paolo Peterlongo,et al.  Identification of fifteen novel germline variants in the BRCA1 3′UTR reveals a variant in a breast cancer case that introduces a functional miR‐103 target site , 2012, Human mutation.

[11]  Wei Zhao,et al.  miR-335 suppresses migration and invasion by targeting ROCK1 in osteosarcoma cells , 2013, Molecular and Cellular Biochemistry.

[12]  A. Gadducci,et al.  Micro-RNAs and ovarian cancer: the state of art and perspectives of clinical research , 2014, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[13]  G. Berx,et al.  SIP1/ZEB2 induces EMT by repressing genes of different epithelial cell–cell junctions , 2005, Nucleic acids research.

[14]  Yimin Xiong,et al.  Identification of hsa-miR-335 as a Prognostic Signature in Gastric Cancer , 2012, PloS one.

[15]  J. Foidart,et al.  Regulation of vimentin by SIP1 in human epithelial breast tumor cells , 2006, Oncogene.

[16]  H. Baba,et al.  MicroRNA-200b Regulates Cell Proliferation, Invasion, and Migration by Directly Targeting ZEB2 in Gastric Carcinoma , 2012, Annals of Surgical Oncology.

[17]  S. Zhang,et al.  Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients. , 2013, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

[18]  A. Jemal,et al.  Cancer Statistics, 2006 , 2006, CA: a cancer journal for clinicians.

[19]  J. Yun,et al.  Overexpression of ZEB2 in Peritumoral Liver Tissue Correlates with Favorable Survival after Curative Resection of Hepatocellular Carcinoma , 2012, PloS one.

[20]  G. Berx,et al.  The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. , 2001, Molecular cell.

[21]  Wei Ping,et al.  Genetic variation in a miR-335 binding site in BIRC5 alters susceptibility to lung cancer in Chinese Han populations. , 2013, Biochemical and biophysical research communications.

[22]  C. Schneider,et al.  miR-335 directly targets Rb1 (pRb/p105) in a proximal connection to p53-dependent stress response. , 2010, Cancer research.

[23]  张静,et al.  Banana Ovate family protein MaOFP1 and MADS-box protein MuMADS1 antagonistically regulated banana fruit ripening , 2015 .

[24]  Margaret S. Ebert,et al.  Roles for MicroRNAs in Conferring Robustness to Biological Processes , 2012, Cell.

[25]  Guoqiang Zhao,et al.  Effect of miR-335 upregulation on the apoptosis and invasion of lung cancer cell A549 and H1299 , 2013, Tumor Biology.

[26]  F. Slack,et al.  Oncomirs — microRNAs with a role in cancer , 2006, Nature Reviews Cancer.

[27]  H. Allgayer,et al.  MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer , 2008, Oncogene.

[28]  Héctor Peinado,et al.  Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? , 2007, Nature Reviews Cancer.

[29]  Yi-Wei Chen,et al.  Epithelial-mesenchymal transition transcription factor ZEB1/ZEB2 co-expression predicts poor prognosis and maintains tumor-initiating properties in head and neck cancer. , 2013, Oral oncology.

[30]  Jin Cao,et al.  miR-335 represents an independent prognostic marker in epithelial ovarian cancer. , 2014, American journal of clinical pathology.

[31]  D. Welch,et al.  Metastamir: the field of metastasis-regulatory microRNA is spreading. , 2009, Cancer research.

[32]  B. Nordlinger,et al.  Colorectal cancer , 2010, The Lancet.